bioRxivBiophysicsPreprint
Structure-based design of a chemical probe set for the 5-HT5A serotonin receptor
A. L. Kaplan, R. T. Strachan, J. M. Braz, V. Craik, S. Slocum, T. Mangano, V. Amabo, H. R. O'Donnell, P. Lak, A. Basbaum, B. L. Roth, B. K. Shoichet
Abstract
The 5-HT5A receptor (5-HT5AR), for which no selective agonists and only a few antagonists exist, remains the least understood serotonin (5-HT) receptor. A single commercial antagonist (SB-699551) has been widely used to investigate central nervous system (CNS) 5-HT5AR function in neurological disorders, including pain. However, because SB-699551 has affinity for many 5-HTRs, lacks inactive property-matched controls, and has assay interference concerns, it has liabilities as a chemical probe. To better illuminate 5-HT5AR function, we developed a probe set through iterative rounds of molecular docking, pharmacological testing, and optimization. Docking over six million lead-like molecules against a 5-HT5AR homology model identified five mid-M ligand starting points with unique scaffolds. Over multiple rounds of structure-based design and testing, a new quinoline scaffold with high affinity and enhanced selectivity for the 5-HT5AR was developed, leading to UCSF678, a 42 nM arrestin-biased partial agonist at the 5-HT5AR with a much more restricted off-target profile and decreased assay liabilities vs. SB-699551. Site-directed mutagenesis supported the docked pose of UCSF678, which was also consistent with recent published 5-HTR structures. Surprisingly, property-matched analogs of UCSF678 that were either inactive across 5-HTRs or retained affinity for UCSF678s off-targets revealed that 5-HT5AR engagement is nonessential for alleviating pain in a mouse model, contrary to previous studies using less-selective ligands. Relative to SB-699551, these molecules constitute a well-characterized and more selective probe set with which to study the function of the 5-HT5A receptor. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/471449v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@8fb24dorg.highwire.dtl.DTLVardef@2dd84org.highwire.dtl.DTLVardef@1d3346org.highwire.dtl.DTLVardef@1117331_HPS_FORMAT_FIGEXP M_FIG Table of Contents Graphic C_FIG
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of a functionally selective serotonin 5-HT1A receptor agonist for the treatment of pain
A. Ullrich, J. Schneider, … P. Gmeiner·bioRxiv·Sep 11, 2023
- TARGETING 5-HT7 RECEPTOR WITH BIASED LIGANDS TO ALLEVIATE PAIN AND SPINAL NEUROINFLAMMATION
Fahima Madouri, Cyril Guimpied, … Séverine Morisset‐Lopez·ACS Chemical NeurosciencePeer-reviewed·May 29, 2026
- Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqalpha
Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia·FEBS LettersPeer-reviewed·Jan 26, 2025
- Crystal structure of the M5 muscarinic acetylcholine receptor
Z. Vuckovic, P. R. Gentry, … D. M. Thal·bioRxiv·Aug 14, 2019
- Crystal structures of the σ2 receptor template large-library docking for selective chemotypes active in vivo
A. Alon, J. Lyu, … A. C. Kruse·bioRxiv·Apr 29, 2021
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
E. Lyapina, E. Marin, … V. Cherezov·bioRxiv·Feb 25, 2022